Nautilus Biotechnology
Business Services · Washington, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
2701 Eastlake Ave E, Seattle, Washington...Phone Number
(206) 333-2001Website
nautilus.bioRevenue
<$5 MillionStock Symbol
NAUTIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
2
1
1
2
2
1
About Nautilus Biotechnology
Nautilus is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The company was established in 2016 and is based out of Seattle, WA.Explore more
Nautilus Biotechnology Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Nautilus Biotechnology your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Nautilus Biotechnology, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Nautilus Biotechnology has recently received funding, and reach out quickly before it becomes old news!
Check out if Nautilus Biotechnology is spiking on competitors!
Funding: Get notified immidiatlly once Nautilus Biotechnology has new funding data
Congratulate Masked Content for being promoted to Masked Content at Nautilus Biotechnology
Earning: See what the market has to say on Nautilus Biotechnology recently announced quarterly report
Website visits: Recent activity has been detected on your website
Click to see if Nautilus Biotechnology had a recent Job posting/layoffs
Product Launch: Get notified when Nautilus Biotechnology launches new products
Recommended Actions
Reach out to Masked Content who joined Nautilus Biotechnology as Masked Content
Find 2 more new buyers
Compare Similar Companies to Nautilus Biotechnology
Compare insights from companies similar to Nautilus Biotechnology, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$21.8M
51-200
Private
-
2011
Hideaki NomuraCEO JSR Life Sciences Corporation General Manager, Bioprocess Department, Life Science Division JSR Corporation
Company Profile Activity
Activity Insights
Nautilus Biotechnology is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Nautilus Biotechnology is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Nautilus Biotechnology.
Nautilus Biotechnology Tech Stack
A closer look at the technologies used by Nautilus Biotechnology
See more technologies
Most Recent Scoops
Project
Nautilus Biotechnology has announced that beta unit placement for its Voyager platform is on track for this year, with pre-orders expected to open in early 2027 and shipments beginning mid-2027, aligned with the release of proteoform assay consumables.
Project
Nautilus Biotechnology has reported data showing that different APOE genetic risk variants carry distinct tau proteoform signatures, and that model systems widely used in Alzheimer's research exhibit markedly different tau proteoform landscapes from one another findings the company believes are only measurable on its platform.
Medical Research
Project
Nautilus Biotechnology has highlighted that its platform is the only one capable of measuring proteoforms at scale combining isoform and multiple post-translational modification data a capability customers have confirmed is critical for understanding signaling pathways, identifying effective therapeutics, and targeting the appropriate patient populations.
Medical Research, Healthcare Technology
Project
Nautilus Biotechnology has announced a target instrument price point of approximately $1 million, supported by market research and a formal conjoint analysis, with final pricing to be confirmed before pre-orders open in early 2027, and assay consumable kits expected to be priced at approximately a few thousand dollars per sample with some variation by target.
Forecasting, Pricing
Project
Medical Research, Pharmaceuticals
Nautilus Biotechnology News & Media
Nautilus Biotechnology Q2 Earnings Call Highlights
Nautilus Biotechnology (NASDAQ:NAUT) said it is shifting a significant share of its research and development resources toward proteoform applications, citing customer interest and a delay in its Broadscale broad-proteome program. Chief Executive Officer Sujal Patel said the company’s platform has dNautilus Biotechnology Reports Second Quarter 2026 Financial Results
SEATTLE, July 28, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the second quarter ended June 30, 2026.Nautilus Biotechnology to Announce Second Quarter 2026 Financial Results on July 28, 2026
SEATTLE, July 08, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced it will report financial results for the second quarter 2026 before market open on Tuesday, July 28, 2026.Nautilus Biotechnology, Inc. (NAUT) Q1 2026 Earnings Call Transcript
Nautilus Biotechnology, Inc. (NAUT) Q1 2026 Earnings Call April 28, 2026 8:30 AM EDTCompany ParticipantsSujal Patel - Co-Founder, CEO, President, Secretary...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Nautilus Biotechnology
Sign Up For FreeTo access detailed company insights
Nautilus is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The company was established in 2016 and is based out of Seattle, WA.... Read More
